Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
McKesson
UBS
Chubb
Argus Health
Covington
Colorcon
Chinese Patent Office
Merck

Generated: April 20, 2018

DrugPatentWatch Database Preview

Claims for Patent: 8,088,407

« Back to Dashboard

Summary for Patent: 8,088,407
Title:Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
Abstract: Methods for reducing or preventing transplant rejection in the eye of an individual are described, comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.
Inventor(s): Wong; Vernon G (Menlo Park, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:11/852,223
Patent Claims: 1. A method for treating edema in an eye of an individual, comprising: placing a bioerodible drug delivery system comprising dexamethasone and a bioerodible polymer in an eye of an individual, thereby treating edema of the eye of the individual.

2. The method of claim 1, wherein the placing compromises placing the bioerodible drug delivery system in the vitreous of the eye.

3. The method of claim 1, wherein the bioerodible polymer comprises a polylactic acid polyglycolic acid (PLGA) copolymer.

4. The method of claim 1, wherein the bioerodible drug delivery system delivers the immunosuppressive agent for at least 5 days.

5. The method of claim 1, wherein the bioerodible drug delivery system delivers the immunosuppressive agent for at least about 3 weeks with the remarks beginning on the following page.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Julphar
Deloitte
Cerilliant
Chubb
QuintilesIMS
Express Scripts
Citi
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.